Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001578421-13-000001
Filing Date
2013-06-11
Accepted
2013-06-10 17:35:13
Documents
1
Effectiveness Date
2013-06-11
Items
Item 04: Rule 504(b)(1) (not (i), (ii) or (iii))

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4688
  Complete submission text file 0001578421-13-000001.txt   5725
Mailing Address 474 LIBERTY ST. SAN FRANCISCO CA 94114
Business Address 474 LIBERTY ST. SAN FRANCISCO CA 94114 415-5056099
G2B Pharma, Inc. (Filer) CIK: 0001578421 (see all company filings)

EIN.: 270468194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-197749 | Film No.: 13904402